O'Bryan R - Search Results

1

Respiratory resistance from 1 to 46 ATA measured with the interrupter technique.

Clarke JR, Jaeger MJ, Zumrick JL, O'Bryan R, Spaur WH. Clarke JR, et al. J Appl Physiol Respir Environ Exerc Physiol. 1982 Mar;52(3):549-55. doi: 10.1152/jappl.1982.52.3.549. J Appl Physiol Respir Environ Exerc Physiol. 1982. PMID: 6461620

2

Maximal physical-work capacity of man at 43.4 ATA.

Dwyer J, Saltzman HA, O'Bryan R. Dwyer J, et al. Undersea Biomed Res. 1977 Dec;4(4):359-72. Undersea Biomed Res. 1977. PMID: 601908 No abstract available.

3

Improving Outcomes for Patients With Tracheostomy Through Implementation of AARC Clinical Practice Guidelines.

Devlin CJ, O'Bryan RS, Williams H, Capes KM, McCants T, Schoolcraft E. Devlin CJ, et al. Among authors: o bryan rs. Respir Care. 2024 Nov 12:respcare.12080. doi: 10.4187/respcare.12080. Online ahead of print. Respir Care. 2024. PMID: 39532496

4

Nerve Conduction Studies of the Larynx: Porcine Model and Human Application.

Libke ML, Chen LW, O'Bryan R, Takacs S, Calcagno H, Zhang L, Halum S. Libke ML, et al. Among authors: o bryan r. J Voice. 2024 Apr 24:S0892-1997(24)00125-5. doi: 10.1016/j.jvoice.2024.04.008. Online ahead of print. J Voice. 2024. PMID: 38664167

5

Nerve Conduction Studies: Basic Concepts and Patterns of Abnormalities.

O'Bryan R, Kincaid J. O'Bryan R, et al. Neurol Clin. 2021 Nov;39(4):897-917. doi: 10.1016/j.ncl.2021.06.002. Epub 2021 Sep 3. Neurol Clin. 2021. PMID: 34602218 Review.

6

Disturbances of visual motion perception in bipolar disorder.

O'Bryan RA, Brenner CA, Hetrick WP, O'Donnell BF. O'Bryan RA, et al. Bipolar Disord. 2014 Jun;16(4):354-65. doi: 10.1111/bdi.12173. Epub 2014 Jan 2. Bipolar Disord. 2014. PMID: 24382259 Free PMC article.

7

Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients.

Velanovich V, Gabel M, Walker EM, Doyle TJ, O'Bryan RM, Szymanski W, Ferrara JJ, Lewis FR Jr. Velanovich V, et al. Among authors: o bryan rm. J Am Coll Surg. 2002 Jan;194(1):8-13. doi: 10.1016/s1072-7515(01)01132-2. J Am Coll Surg. 2002. PMID: 11800343

8

Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.

Budd GT, Green S, O'Bryan RM, Martino S, Abeloff MD, Rinehart JJ, Hahn R, Harris J, Tormey D, O'Sullivan J, et al. Budd GT, et al. Among authors: o bryan rm. J Clin Oncol. 1995 Apr;13(4):831-9. doi: 10.1200/JCO.1995.13.4.831. J Clin Oncol. 1995. PMID: 7707108 Clinical Trial.

9

Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trial.

Hayden KA, Moinpour CM, Metch B, Feigl P, O'Bryan RM, Green S, Osborne CK. Hayden KA, et al. Among authors: o bryan rm. Oncol Nurs Forum. 1993 Oct;20(9):1415-9. Oncol Nurs Forum. 1993. PMID: 8265446

10

One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.

Rivkin SE, Green S, Metch B, Jewell WR, Costanzi JJ, Altman SJ, Minton JP, O'Bryan RM, Osborne CK. Rivkin SE, et al. Among authors: o bryan rm. J Clin Oncol. 1993 Sep;11(9):1710-6. doi: 10.1200/JCO.1993.11.9.1710. J Clin Oncol. 1993. PMID: 8355037 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters